RxDoctor Payments Data

James Douglas, MD

Family Medicine · Bowling Green, KYNPI 1790785954

Payments from drug & device makers

$10,407in general payments, 2019–2025

Across 786 payments — averaging $13.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • AbbVie$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$627
  • Boehringer Ingelheim$512
  • AstraZeneca$465
  • plus $5K from 46 others

What the payments were for

  • Food & beverage$10,400100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,407 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$204,580
Medicare patients
967
Services billed
17,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin206$199,985
OzempicSemaglutide177$188,360
EliquisApixaban176$136,581
MounjaroTirzepatide108$124,697
FarxigaDapagliflozin Propanediol61$63,552
RybelsusSemaglutide22$51,011
LinzessLinaclotide59$43,259
TrulicityDulaglutide16$41,787
JanuviaSitagliptin Phosphate49$41,750
Tresiba Flextouch U-200Insulin Degludec38$36,787
XareltoRivaroxaban27$32,166
ProliaDenosumab18$31,334
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$27,492
TrintellixVortioxetine Hydrobromide48$22,605
MyrbetriqMirabegron34$17,779

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,354$239,372199 claims
Boehringer IngelheimJardiance$512$199,985206 claims
Lilly USA, LLCMounjaro, Trulicity$627$166,484124 claims
PfizerEliquis, Premarin$1,436$139,638195 claims
AstraZenecaFarxiga, Brilinta, Breztri Aerosphere, Nexium$465$94,578127 claims
AbbVieLinzess, Synthroid$1,367$51,826203 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$353$47,24373 claims
MerckJanuvia$222$41,75049 claims
Johnson & JohnsonXarelto$92$32,16627 claims
AmgenProlia$252$31,33418 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$445$22,60548 claims
Astellas Pharma US IncMyrbetriq$124$17,77934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →